South African telehealth platform, Contro, has introduced a R10.1 million (~$582,000) pre-seed spherical, which included participation from buyers Plug & Play, iCubed Capital, WZ Capital, and the Jozi Angels Community, in addition to grant funding from the i3 fund backed by the Invoice & Melinda Gates Basis.
Contro launched in June 2021 and at the moment presents six providers, together with subscription providers for contraception, erectile dysfunction therapy and hair loss therapy, in addition to once-off therapy for STIs, thrush and UTIs.
The startup claims that its platform has facilitated therapy for over 2000 individuals throughout South Africa thus far. Talking on the funding spherical, Contro’s founder, Alex Schmid said that they’ve been capable of construct a service that basically makes entry to well being providers simpler and cheaper and discreet than ever earlier than.
“I’m extremely happy with the work our staff has produced, the hours devoted and the weekends sacrificed to get the corporate the place it’s in the present day. Buyers have witnessed that willpower and the potential Contro has, which has proudly resulted in distinctive VCs, Angels and the Invoice & Melinda Gates Basis backing us and our platform,” he added.
Contro will use the funding to additional develop its platform and broaden its providers, in addition to develop its staff, with the aim of facilitating focused development throughout South Africa the place 30% of its buyer base originates from the townships and rural areas.
“Our largest achievement thus far has been creating an accessible and reasonably priced service for all South Africans. The platform is utilized in areas comparable to Soweto, Khayelitsha, and Alexandra, in addition to rural areas, and we’re one of many few corporations that may facilitate each consultations and drugs supply to anyplace in South Africa. As a South African founding staff, this has humbled us, and this achievement is what drives us to proceed to develop our platform and firm to ship healthcare to all,” concluded Schmid.